We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Analysis in Real Time Helps Brain Surgeons Remove More Cancerous Tissue

By HospiMedica International staff writers
Posted on 20 Dec 2011
A combination of surgical aspiration and mass spectrometry can determine whether brain tissue is normal or cancerous while surgery is underway, according to a new study. More...


Researchers at Justus Liebig University (JLU; Giessen, Germany), the University of Debrecen (Hungary), and other institutions used a direct combination of a cavitron ultrasonic surgical aspirator (CUSA) and a venturi easy ambient sonic-spray ionization (V-EASI) source to nebulize efficiently suspended tissue material for gas phase ion production. Positive and negative ionization spectra were identified using mass spectrometry, which featured predominantly complex lipid-type constituents in both ion polarity modes. Multiply charged peptide anions were also detected. The spectra of the intact tissue specimens were found to be highly specific to the histological tissue type.

The researchers then examined the influence of instrumental settings, using standard solutions of phospholipids and peptides to test the dynamic range, sensitivity, and suppression effects in detail. Venturi pump geometry and flow parameters were found to be critically important in ionization efficiency. The researchers subsequently developed a real-time tissue identification method for the surgical environment, using principal component analysis (PCA) and linear-discriminant analysis (LDA) based data to identify the margin between cancerous and healthy tissue in half the time previously needed. The study was published in the October 15, 2011, issue of Analytical Chemistry.

“The method has been successfully tested on postmortem and ex vivo human samples including astrocytomas, meningeomas, metastatic brain tumors, and healthy brain tissue,” wrote corresponding author Zoltan Takats, PhD, of the JLU Institute for Inorganic und Analytical Chemistry, and colleagues. “Besides brain surgery, the method has application potential in the field of the surgery of organs including liver, pancreas, or kidney.”

Related Links:

Justus Liebig University
University of Debrecen


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.